MOSCOW (MRC) -- INVISTA Technologies, a world leader in fibers, resins and chemical intermediates, and Arzeda Corp., an emerging Seattle-based biotechnology company, have entered into strategic partneship for the development of new technologies to enable novel bio-derived processes, according to Businesswire.
The agreement brings together complementary technologies: INVISTA’s capabilities in biotechnology and catalysis, and knowledge of the chemicals industry; and Arzeda’s unique synthetic biology and enzyme design capabilities. The two companies are collaborating in order to further co-develop their technology platforms, with the goal to ultimately develop new bio-derived processes for a range of products.
We remind that, as MRC reported previously, Invista Performance Technologies had acquired from La Seda de Barcelona SA intellectual property relating to its leading purified terephthalic acid (PTA), polyethylene terephthalate (PET) and related process technologies, including the full rights to exclusively license the technologies in the region comprising Europe, the Middle East and Africa.
Arzeda, an emerging Seattle-based biotechnology company, is pioneering a new synthetic biology with its computational enzyme design technology. Arzeda creates value for its partners in the agricultural and industrial biotechnology sectors by designing novel, reaction-specific optimized enzymes and designer organisms leveraging synthetic metabolic pathways.
INVISTA is one of the world’s largest integrated producers of polymers and fibers, primarily for nylon, spandex and polyester applications. With a business presence in over 20 countries, INVISTA’s global businesses deliver exceptional value for their customers through technology innovations, market insights and a powerful portfolio of global trademarks.
MRC